Literature DB >> 32996448

Importance of Follow-Up Microscopic Examination in Hospitalized Patients with Confirmed Scabies.

Miseo Kim1, Sun-Kyung Kim1, Min Jee Hong1, Sun Hee Kwak1, Eun Ok Kim1, Moonsuk Bae2, Min Jae Kim2, Woo Jin Lee3, Sung-Han Kim1,2, Jiwon Jung1,2, Sung Eun Chang3.   

Abstract

We investigated the duration of positive microscopic examination in hospitalized patients with confirmed scabies in an acute care hospital. We included hospitalized patients who were diagnosed with scabies between January 2015 and June 2019. From the study period, a total of 31 patients with confirmed scabies were identified. Median age was 75 years. Of a total of 31 patients with confirmed scabies, six were discharged or transferred before getting a negative microscopic test result. Of the remaining 25 patients with negative microscopic test results, the median duration from diagnosis to a negative microscopic test result was 14 days (interquartile range, 9-17). Given that nosocomial outbreaks lead to high workload and considerable resource consumption, adequate treatment, sufficient follow-up examination, and confirmation of cure are warranted before releasing contact isolation.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32996448      PMCID: PMC7695111          DOI: 10.4269/ajtmh.20-0318

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  10 in total

1.  European guideline for the management of scabies.

Authors:  C M Salavastru; O Chosidow; M J Boffa; M Janier; G S Tiplica
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-06-22       Impact factor: 6.166

2.  Comparison of dermoscopy, skin scraping, and the adhesive tape test for the diagnosis of scabies in a resource-poor setting.

Authors:  Birke Walter; Jörg Heukelbach; Gernot Fengler; Christine Worth; Ulrich Hengge; Hermann Feldmeier
Journal:  Arch Dermatol       Date:  2011-04

Review 3.  Permethrin and ivermectin for scabies.

Authors:  Bart J Currie; James S McCarthy
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

4.  Treatment of scabies: Comparison of permethrin 5% versus ivermectin.

Authors:  Mohamad Goldust; Elham Rezaee; Sevil Hemayat
Journal:  J Dermatol       Date:  2012-03-05       Impact factor: 4.005

5.  A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies.

Authors:  V Usha; T V Gopalakrishnan Nair
Journal:  J Am Acad Dermatol       Date:  2000-02       Impact factor: 11.527

6.  Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis.

Authors:  S F Walton; M R Myerscough; B J Currie
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Jan-Feb       Impact factor: 2.184

7.  Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies.

Authors:  M W Schultz; M Gomez; R C Hansen; J Mills; A Menter; H Rodgers; F N Judson; G Mertz; H H Handsfield
Journal:  Arch Dermatol       Date:  1990-02

8.  In vitro ovicidal activity of current and under-development scabicides: which treatments kill scabies eggs?

Authors:  C Bernigaud; D D Fernando; H Lu; S Taylor; G Hartel; J Guillot; O Chosidow; K Fischer
Journal:  Br J Dermatol       Date:  2019-11-07       Impact factor: 9.302

9.  Identifying the time to cure for patients with classic scabies after infection control intervention in acute care hospital settings.

Authors:  Jebyung Park; Se Yoon Park; Jaijun Han; So Young Lee; Gil Eun Kim; Yeon Su Jeong; Jin Hwa Kim; Eun Jung Lee; Eunyoung Lee; Tae Hyong Kim
Journal:  Am J Infect Control       Date:  2018-12-05       Impact factor: 2.918

10.  Comparative trial of permethrin 5% versus lindane 1% for the treatment of scabies.

Authors:  Mohamad Goldust; Shahla Babae Nejad; Elham Rezaee; Ramin Raghifar
Journal:  J Dermatolog Treat       Date:  2013-01-20       Impact factor: 3.359

  10 in total
  1 in total

1.  Recurrence of Classic Scabies in a Patient Who had Unchanged Tie String of the T-Cannula.

Authors:  Jiwon Jung; Jihye Jeong; Min Jee Hong; Eun Ok Kim; Min Jae Kim; Sung Eun Chang; Sung-Han Kim
Journal:  Infect Chemother       Date:  2021-12-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.